HK1150614A1 - 生物材料及其用途 - Google Patents
生物材料及其用途Info
- Publication number
- HK1150614A1 HK1150614A1 HK11104584.1A HK11104584A HK1150614A1 HK 1150614 A1 HK1150614 A1 HK 1150614A1 HK 11104584 A HK11104584 A HK 11104584A HK 1150614 A1 HK1150614 A1 HK 1150614A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- biological materials
- biological
- materials
- Prior art date
Links
- 239000012620 biological material Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0803369.8A GB0803369D0 (en) | 2008-02-25 | 2008-02-25 | Biological materials and uses thereof |
PCT/GB2009/000522 WO2009106819A2 (en) | 2008-02-25 | 2009-02-25 | Biological materials and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1150614A1 true HK1150614A1 (zh) | 2012-01-06 |
Family
ID=39284484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11104584.1A HK1150614A1 (zh) | 2008-02-25 | 2011-05-09 | 生物材料及其用途 |
Country Status (16)
Country | Link |
---|---|
US (2) | US9085632B2 (zh) |
EP (1) | EP2247608B1 (zh) |
JP (2) | JP2011513215A (zh) |
KR (1) | KR101776157B1 (zh) |
CN (1) | CN101965361B (zh) |
AU (1) | AU2009219992B2 (zh) |
BR (1) | BRPI0908259A2 (zh) |
CA (1) | CA2713095C (zh) |
ES (1) | ES2513392T3 (zh) |
GB (1) | GB0803369D0 (zh) |
HK (1) | HK1150614A1 (zh) |
IL (1) | IL207216A (zh) |
MX (1) | MX2010009373A (zh) |
RU (1) | RU2508296C2 (zh) |
WO (1) | WO2009106819A2 (zh) |
ZA (1) | ZA201004899B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0226105D0 (en) | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
GB201118201D0 (en) * | 2011-10-21 | 2011-12-07 | Helperby Therapeutics Ltd | Novel peptides |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
EP2991634A1 (en) | 2013-04-30 | 2016-03-09 | Otitopic Inc. | Dry powder formulations and methods of use |
GB201700555D0 (en) | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Method for the treatment of a relapsing-remitting condition |
GB201700557D0 (en) | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Novel peptides |
US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
CN111315363B (zh) | 2017-09-22 | 2022-10-11 | 奥迪托皮克股份有限公司 | 含有硬脂酸镁的干粉组合物 |
AU2023221589A1 (en) | 2022-02-17 | 2024-08-22 | Revolo Biotherapeutics Limited | Method of producing peptide derived from chaperonin 60.1 |
WO2023223015A1 (en) | 2022-05-16 | 2023-11-23 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating food allergies |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1300749A (zh) * | 1999-12-21 | 2001-06-27 | 复旦大学 | 一种新的多肽-分子伴侣cpn60蛋白13和编码这种多肽的多核苷酸 |
GB0028122D0 (en) | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
-
2008
- 2008-02-25 GB GBGB0803369.8A patent/GB0803369D0/en not_active Ceased
-
2009
- 2009-02-25 MX MX2010009373A patent/MX2010009373A/es active IP Right Grant
- 2009-02-25 KR KR1020107021315A patent/KR101776157B1/ko active IP Right Grant
- 2009-02-25 CN CN200980106390.8A patent/CN101965361B/zh active Active
- 2009-02-25 ES ES09714217.8T patent/ES2513392T3/es active Active
- 2009-02-25 US US12/918,789 patent/US9085632B2/en active Active
- 2009-02-25 WO PCT/GB2009/000522 patent/WO2009106819A2/en active Application Filing
- 2009-02-25 AU AU2009219992A patent/AU2009219992B2/en active Active
- 2009-02-25 BR BRPI0908259-0A patent/BRPI0908259A2/pt not_active IP Right Cessation
- 2009-02-25 CA CA2713095A patent/CA2713095C/en active Active
- 2009-02-25 JP JP2010547254A patent/JP2011513215A/ja active Pending
- 2009-02-25 EP EP09714217.8A patent/EP2247608B1/en active Active
- 2009-02-25 RU RU2010139402/10A patent/RU2508296C2/ru active
-
2010
- 2010-07-12 ZA ZA2010/04899A patent/ZA201004899B/en unknown
- 2010-07-26 IL IL207216A patent/IL207216A/en active IP Right Grant
-
2011
- 2011-05-09 HK HK11104584.1A patent/HK1150614A1/zh not_active IP Right Cessation
-
2014
- 2014-03-20 JP JP2014058470A patent/JP5906269B2/ja active Active
-
2015
- 2015-07-17 US US14/803,020 patent/US20160017009A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2713095C (en) | 2018-09-11 |
JP5906269B2 (ja) | 2016-04-20 |
CA2713095A1 (en) | 2009-09-03 |
CN101965361B (zh) | 2014-07-09 |
IL207216A (en) | 2014-12-31 |
RU2010139402A (ru) | 2012-04-10 |
ES2513392T3 (es) | 2014-10-27 |
BRPI0908259A2 (pt) | 2015-07-21 |
ZA201004899B (en) | 2011-09-28 |
US9085632B2 (en) | 2015-07-21 |
AU2009219992B2 (en) | 2014-04-03 |
MX2010009373A (es) | 2010-12-06 |
EP2247608B1 (en) | 2014-07-23 |
EP2247608A2 (en) | 2010-11-10 |
RU2508296C2 (ru) | 2014-02-27 |
CN101965361A (zh) | 2011-02-02 |
US20110052616A1 (en) | 2011-03-03 |
KR101776157B1 (ko) | 2017-09-07 |
WO2009106819A2 (en) | 2009-09-03 |
AU2009219992A1 (en) | 2009-09-03 |
WO2009106819A3 (en) | 2009-10-22 |
US20160017009A1 (en) | 2016-01-21 |
KR20100138962A (ko) | 2010-12-31 |
JP2014158471A (ja) | 2014-09-04 |
IL207216A0 (en) | 2010-12-30 |
GB0803369D0 (en) | 2008-04-02 |
JP2011513215A (ja) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
IL210804A (en) | Benzylidenehydrazides and their uses | |
IL209309A0 (en) | Anti-fn14 antibodies and uses thereof | |
IL216731A (en) | And antibodies against p95 – her2 and their uses | |
HK1150614A1 (zh) | 生物材料及其用途 | |
GB0904825D0 (en) | Biological materials and uses thereof | |
HK1199888A1 (zh) | 生物材料及其用途 | |
HK1210026A1 (zh) | 巰基官能化試劑及其用途 | |
ZA201103456B (en) | Leukolectins and uses thereof | |
EP2291377A4 (en) | IMIDAZOPYRIMIDINONE AND ITS USES | |
PL2247601T3 (pl) | Tiazopirymidynony i ich zastosowanie | |
EP2388320A4 (en) | ANTI-HS6ST2 ANTIBODIES AND USE THEREOF | |
GB0701062D0 (en) | Biological materials and uses thereof | |
GB0811362D0 (en) | Biological materials and uses thereof | |
GB0606269D0 (en) | Biological materials and uses thereof | |
GB0802980D0 (en) | Biological materials and uses thereof | |
GB0812277D0 (en) | Antibody and uses thereof | |
GB0922143D0 (en) | Biological materials and uses thereof | |
GB0617241D0 (en) | Biological materials and uses thereof | |
GB0802075D0 (en) | Biological materials and uses thereof | |
GB0808956D0 (en) | biological materials and uses thereof | |
GB0708001D0 (en) | Biological materials and uses thereof | |
GB0718781D0 (en) | Biological materials and uses thereof | |
GB0711926D0 (en) | Biological materials and uses thereof | |
GB0606268D0 (en) | Biological materials and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220219 |